51186-58-4

Basic information

• Product Name: Boc-D-aspartic acid 4-benzyl ester
• Synonyms: T-BUTYLOXYCARBONYL-D-ASPARTIC ACID BETA-BENZYL ESTER;(R)-2-TERT-BUTOXYCARBONYLAMINO-SUCCINIC ACID 1-BENZYL ESTER;N-ALPHA-T-BUTYLOXYCARBONYL-D-ASPARTIC ACID BETA-BENZYL ESTER;N-ALPHA-TERT-BUTYLOXYCARBONYL-D-ASPARTIC ACID BETA-BENZYL ESTER;N-ALPHA-T-BOC-D-ASPARTIC ACID BETA-BENZYL ESTER;N-ALPHA-T-BUTOXYCARBONYL-D-ASPARTIC ACID ALPHA-BENZYL ESTER;BOC-D-ASPARTIC ACID 4-BENZYL ESTER;BOC-D-ASPARTIC ACID ALPHA-BENZYL ESTER
• CAS NO: 51186-58-4
• Molecular Formula: C₁₆H₂₁NO₆
• Molecular Weight: 323.34
• Product Categories: Amino Acids;Aspartic acid [Asp, D];Boc-Amino Acids and Derivative;Boc-Amino acid series
• Mol File: 51186-58-4.mol

Chemical Properties

• Boiling Point: 508.1 °C at 760 mmHg
• Flash Point: 261.1 °C
• Appearance: White to off-white/Powder
• Density: 1.219 g/cm³
• Storage Temp.: Store at 0-5°C
• PKA: 3.65±0.23(Predicted)
• BRN: 2305471
• CAS DataBase Reference: Boc-D-aspartic acid 4-benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Boc-D-aspartic acid 4-benzyl ester(51186-58-4)
• EPA Substance Registry System: Boc-D-aspartic acid 4-benzyl ester(51186-58-4)

Safety Data

• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 51186-58-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
Boc-D-aspartic acid 4-benzyl ester is used as an intermediate in organic synthesis for the production of various chemical compounds. Its unique structure allows for selective reactions and functional group manipulations, making it a valuable building block in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Boc-D-aspartic acid 4-benzyl ester is used as an intermediate in the synthesis of drugs and drug candidates. Its incorporation into drug molecules can provide specific biological activities or improve the pharmacokinetic properties of the final product, such as solubility, stability, or bioavailability.
Used in Research and Development:
Boc-D-aspartic acid 4-benzyl ester is also employed in research and development for the study of various biological processes and the development of new therapeutic strategies. Its unique structural features make it an attractive candidate for the design and synthesis of novel bioactive molecules with potential applications in medicine and biotechnology.

Upstream product

• 1070-19-5 N-(tert-butyloxycarbonyl) azide 
• 2177-63-1 D-aspartic acid β-benzyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 51186-59-5 Boc-D-Asp(-O-CH₂C₆H₅)-Asp-NH₂ 
• 128164-22-7 BOC-D-Asp(OBzl)-Glu(OBzl)-OBzl 
• 127103-26-8 BocDAsp(OBzl)Lys(Z)ProOBzl 
• 109318-09-4 (R)-3-tert-Butoxycarbonylamino-N-((R)-1-carbamoyl-pentyl)-succinamic acid benzyl ester 
• 157974-00-0 N-Boc-β-benzyl-D-aspartyl-3,5-dimethylpyrazolide 
• 2177-63-1 D-aspartic acid β-benzyl ester 
• 80963-12-8 α-Methyl β-benzyl (2R)-N-(tert-butoxycarbonyl)aspartate diester 
• 188612-68-2 N,N',N'',N'''-tetrakis[3-benzyloxycarbonyl-2-[(tert-butoxycarbonyl)amino]propanoyl]-2,11,20,29-tetraaza[3.3.3.3]paracyclophane 
• 50896-47-4 Boc-D-Asp(-OCH₂C₆H₅)-O-succinimid 
• 145232-46-8 3-tert-butoxycarbonylamino-N-[2-(4-fluoro-phenyl)-ethyl]-succinamic acid benzyl ester 
• 118247-73-7 BOC-D-Asp(OBn)-2-phenylethylamide 
• 1026301-23-4 N-[1-{1-[1-(benzyloxycarbonylamino-methyl)-2-phenyl-ethylcarbamoyl]-2-phenyl-ethylcarbamoyl}-2-(1H-indol-3-yl)-ethyl]-3-tert-butoxycarbonylamino-succinamic acid benzyl ester 
• 645394-76-9 4-benzyloxycarbonylmethyl-2,5-dioxo-oxazolidine-3-carboxylic acid tert-butyl ester 

Relevant articles and documents

Degradation-promoters of cellular inhibitor of apoptosis protein 1 based on bestatin and actinonin

A series of hybrid compounds of bestatin (1) and actinonin (3), which promote degradation of cellular inhibitor of apoptosis protein 1 (cIAP1), were designed and synthesized. Structure-activity relationship studies indicated that absolute configuration, hydrophobicity at the α-position of the internal amide carbonyl group, and the presence of a small substituent at the α-position of the ester group are important factors for the expression of potent cIAP1 degradation-promoting activity. HAB-5A (30b) showed the most potent activity (IC50 = 0.53 μM) among the compounds prepared.

Novel immunological adjuvant compounds and methods of preparation thereof

This application relates to novel immunological adjuvant compounds of the formula: STR1 wherein each of R and R1 are the same or different and are hydrogen or an acyl radical; R2 is an unsubstituted or substituted alkyl radical, or an unsubstituted or substituted aryl radical; X is an aminoacyl moiety; and Y is D-isoasparagine or D-isoglutamine.